Clinical Focus


  • Neurology

Academic Appointments


Professional Education


  • Board Certification: United Council for Neurologic Subspecialties, Neuro-Oncology (2023)
  • Medical Education: Duke University School of Medicine (2017) NC
  • Internship: Massachusetts General Hospital Internal Medicine Residency (2018) MA
  • Residency: Brigham and Women's and Mass General Hospital Neurology Residency (2021) MA
  • Fellowship: Massachusetts General Dana Farber Neuro Oncology Fellowship (2022) MA
  • Fellowship: Stanford University Dept of Neurology (2023) CA
  • Board Certification: American Board of Psychiatry and Neurology, Neurology (2021)
  • Board Certification, United Council for Neurologic Subspecialties, Neuro-Oncology, Neuro-Oncology (2023)

Clinical Trials


  • Phase I GD2 CAR T Cells for H3K27M-mutant Diffuse Midline Glioma (DMG) Recruiting

    The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.

    View full details